7Baggers
Quarterly
Annual
    Unit: USD2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 
      
    		                                             
      assets
    		                                             
      current assets
    		                                             
      cash and cash equivalents
    		246,662,000 76,497,000 81,331,000 87,928,000 48,413,000 57,024,000 42,847,000 169,681,000 52,437,000 19,368,000 7,874,000 14,602,000 19,751,000 24,065,000 28,974,000 21,304,000 28,185,000 33,596,000 41,607,000 49,224,000 56,137,000 62,499,000 15,070,000 20,733,000 11,225,000 15,503,000 19,402,000 23,099,000 10,239,000 12,593,000 14,866,000 17,099,507 5,647,000 7,547,000 10,539,000 2,725,996 5,415,000 2,502,000 6,492,000 5,494,523 4,720,000 7,530,000 9,529,000 7,956,710 64,000 
      marketable securities
    		252,272,000 210,344,000 208,619,000 203,509,000 208,363,000 209,099,000                                        
      accounts receivable
    		25,506,000 24,624,000                                3,000 110,000 133,337 137,000 288,000 187,000 156,127 94,000 12,000 8,000  37,000 
      inventory
    		6,674,000 2,355,000                                164,000 855,000 660,391 703,000 774,000 653,000 551,008 376,000 277,000 206,000 109,336  
      prepaid expenses and other current assets
    		3,739,000 2,969,000 18,965,000 2,452,000 1,423,000 1,379,000 1,596,000 1,677,000 1,222,000 1,130,000 1,253,000 1,045,000 821,000 824,000 1,004,000 1,118,000 702,000 948,000 921,000 1,019,000 348,000 505,000 572,000 411,000 375,000 471,000 603,000 529,000 327,000 248,000 423,000 342,927 145,000 246,000 261,000 246,570 217,000 157,000 216,000 167,642 225,000 311,000 260,000 252,272 186,000 
      total current assets
    		534,853,000 316,789,000 308,915,000 293,889,000 258,199,000 267,502,000 151,223,000 171,358,000 53,659,000 20,498,000 9,127,000 15,647,000 20,572,000 24,889,000 29,978,000 22,422,000 28,887,000 34,544,000 42,528,000 50,243,000 56,485,000 63,004,000 15,642,000 21,144,000 11,609,000 16,615,000 20,865,000 24,670,000 11,413,000 13,311,000 15,808,000 17,993,807 6,390,000 10,318,000 11,800,000 3,801,294 6,507,000 3,756,000 7,583,000 6,404,300 5,526,000 8,165,000 10,023,000 8,338,318 307,000 
      long-term assets
    		                                             
      property and equipment
    		150,000 166,000 173,000 186,000 196,000 19,000 27,000 12,000 15,000 19,000 22,000 26,000 23,000 28,000 27,000 33,000 26,000 27,000 20,000 19,000 20,000 17,000 19,000 22,000 46,000 22,000 19,000 12,000 14,000 13,000 17,000 22,885 55,000 53,000 93,000 102,560 116,000 118,000 121,000 85,745 98,000 43,000 44,000 57,607 36,000 
      operating lease right-of-use assets
    		2,314,000 2,434,000 2,603,000 2,798,000 2,992,000 268,000 338,000 407,000 474,000 541,000 53,000 131,000 206,000 279,000 350,000 421,000 489,000 558,000 50,000 124,000 195,000 265,000 332,000 398,000                      
      intangible assets
    		5,347,000 5,832,000 6,318,000 6,805,000 7,291,000 7,777,000 8,263,000 8,749,000 9,235,000 9,721,000 10,207,000 10,693,000 11,178,000 11,665,000 12,151,000 12,637,000 13,123,000 13,609,000 14,095,000 14,581,000 15,067,000 15,553,000 16,039,000 16,525,000 17,011,000 17,497,000 17,983,000 18,469,000 18,955,000 19,441,000 19,927,000 20,413,056              
      long-term marketable securities
    		57,148,000 7,002,000  27,211,000 27,945,000 28,482,000                                        
      other long-term assets
    		83,000 83,000 83,000 83,000 83,000 83,000 165,000 165,000 165,000 165,000 126,000    40,000 40,000 40,000 40,000     59,000 59,000 59,000                     
      total assets
    		599,895,000 332,306,000 318,092,000 330,972,000 296,706,000 304,131,000 168,837,000 180,691,000 63,548,000 30,944,000 19,535,000 26,497,000 31,979,000 36,861,000 42,546,000 35,553,000 42,565,000 48,778,000 56,706,000 64,982,000 71,784,000 78,859,000 32,113,000 38,172,000 28,725,000 34,134,000 38,867,000 43,151,000 30,835,000 33,344,000 36,331,000 39,021,665 26,382,000 30,381,000 33,865,000 5,564,852 8,309,000 5,535,000 9,390,000 8,201,195 7,288,000 8,770,000 10,067,000 8,395,925 1,696,000 
      liabilities and stockholders’ equity
    		                                             
      current liabilities
    		                                             
      accounts payable
    		8,145,000 6,216,000 5,483,000 8,882,000 6,243,000 3,716,000 8,022,000 3,149,000 3,216,000 3,442,000 2,778,000 1,777,000 2,324,000 2,406,000 2,411,000 3,254,000 3,858,000 3,348,000 4,669,000 3,489,000 3,213,000 3,657,000 3,480,000 1,995,000 1,735,000 1,740,000 1,258,000 934,000 1,245,000 981,000 1,133,000 633,104 642,000 1,029,000 935,000 537,891 862,000 957,000 1,262,000 695,056 953,000 989,000 621,000 986,799 1,238,000 
      accrued compensation
    		7,248,000 6,267,000 4,277,000 4,776,000 3,408,000 2,149,000 1,226,000 3,135,000 1,498,000 1,165,000 721,000 1,675,000 1,282,000 932,000 598,000 728,000 809,000 652,000 411,000 1,005,000 756,000 520,000 338,000 283,000                      
      operating lease liabilities
    		697,000 676,000 597,000 526,000 448,000 296,000 310,000 273,000   39,000 155,000 239,000 337,000 344,000 282,000 290,000 180,000 57,000 139,000 220,000 298,000 315,000 305,000                      
      other current liabilities
    		17,163,000 5,512,000 3,127,000 2,737,000 3,101,000 1,126,000 1,511,000 1,555,000 848,000 513,000 692,000 484,000 671,000 415,000 439,000 323,000 492,000 255,000 232,000 196,000 408,000 444,000 308,000 382,000                      
      total current liabilities
    		33,253,000 20,943,000 15,731,000 18,747,000 14,962,000 9,150,000 13,464,000 11,505,000 28,993,000 8,798,000 7,761,000 7,313,000 7,342,000 7,246,000 7,313,000 8,007,000 9,042,000 8,362,000 9,509,000 8,618,000 7,996,000 8,363,000 7,287,000 4,964,000 3,454,000 2,855,000 2,250,000 1,877,000 2,508,000 1,945,000 1,942,000 1,732,769 1,731,000 2,122,000 2,172,000 1,707,378 1,777,000 1,901,000 2,579,000 3,192,735 6,028,000 13,349,000 1,059,000 1,289,785 1,596,000 
      long-term liabilities
    		                                             
      contingent liability for essentialis purchase price
    		19,473,000 18,859,000 17,758,000 14,791,000 14,464,000 13,587,000 11,950,000 11,549,000 10,468,000 9,447,000 9,134,000 8,835,000 9,437,000 9,305,000 8,689,000 9,547,000 12,876,000 12,325,000 9,291,000 10,278,000 10,138,000 9,364,000 6,522,000 5,938,000 6,066,000 6,038,000 5,855,000 5,649,000 5,671,000 5,443,000 5,510,000 5,081,840              
      long-term debt
    		49,854,000 49,845,000 49,836,000 49,828,000                                          
      long-term lease liabilities
    		2,112,000 2,248,000 2,361,000 2,472,000 2,581,000  37,000 130,000       79,000 175,000                              
      other long-term liabilities
    		398,000 271,000 145,000 21,000                   60,000 147,000 38,000        1,132,000 1,132,000 1,201,000  196,000 200,000 200,000       
      total liabilities
    		105,090,000 92,166,000 85,831,000 85,859,000 32,007,000 23,374,000 25,451,000 23,184,000 40,328,000 18,518,000 16,896,000 16,149,000 16,779,000 16,553,000 16,085,000 17,760,000 22,362,000 21,341,000 19,138,000 19,435,000 23,778,000 22,682,000 22,632,000 23,225,000 13,840,000 20,291,000 15,236,000 12,738,000 16,630,000 17,507,000 13,312,000 12,486,757 3,172,000 3,693,000 3,721,000 2,129,655     8,579,000 16,402,000 21,370,000   
      commitments and contingencies
    		                                             
      stockholders’ equity
    		                                             
      preferred stock, 0.001 par value; 10,000,000 shares authorized, no shares issued and outstanding
    		                                             
      common stock
    		54,000 50,000 49,000 46,000 41,000 38,000 33,000 32,000 15,000 10,000 8,000 8,000 8,000 120,000 120,000 80,000 80,000 80,000 80,000 80,000 80,000 80,000 45,000 45,000 32,000 32,000 32,000 32,000 21,000 21,000 20,000 19,239 10,000 48,000 47,000 16,786 15,000 15,000 15,000 14,018 12,000 8,000 7,000 6,769 1,000 
      additional paid-in-capital
    		969,119,000 740,746,000 728,019,000 696,966,000 660,041,000 600,534,000 441,267,000 433,885,000 288,320,000 266,669,000 248,393,000 247,762,000 247,130,000 245,993,000 245,422,000 231,068,000 230,650,000 229,744,000 228,887,000 227,912,000 227,519,000 227,145,000 173,100,000 172,708,000 158,034,000 157,881,000 157,661,000 157,413,000 141,479,000 141,187,000 140,733,000 140,494,976 132,154,000 131,807,000 131,296,000 101,730,285 101,395,000 95,543,000 95,255,000 89,456,466 82,099,000 72,469,000 70,679,000 60,635,664 20,741,000 
      accumulated other comprehensive income
    		360,000 85,000         16,000                                   
      accumulated deficit
    		-474,728,000 -500,741,000 -496,033,000 -452,260,000 -396,278,000 -319,662,000 -297,808,000 -276,410,000 -265,114,000 -254,253,000 -245,778,000 -237,422,000 -231,936,000 -225,804,000 -219,079,000 -213,355,000 -210,527,000 -202,387,000 -191,399,000 -182,445,000 -179,593,000 -171,048,000 -163,664,000 -157,806,000 -143,181,000 -144,070,000 -134,062,000 -127,032,000 -127,295,000 -125,371,000 -117,734,000 -113,979,312 -108,954,000 -105,167,000 -101,199,000 -98,311,887 -95,698,000 -92,948,000 -89,436,000 -86,246,673 -83,402,000 -80,109,000 -81,989,000 -70,975,024 -63,120,000 
      total stockholders’ equity
    		494,805,000 240,140,000 232,261,000 245,113,000 264,699,000 280,757,000 143,386,000 157,507,000 23,220,000 12,426,000 2,639,000 10,348,000 15,200,000 20,308,000 26,461,000 17,793,000 20,203,000 27,437,000 37,568,000 45,547,000 48,006,000 56,177,000 9,481,000 14,947,000 14,885,000 13,843,000 23,631,000 30,413,000 14,205,000 15,837,000 23,019,000 26,534,908 23,210,000 26,688,000 30,144,000 3,435,197 5,712,000 2,610,000 5,834,000 3,223,816      
      total liabilities and stockholders’ equity
    		599,895,000 332,306,000 318,092,000 330,972,000 296,706,000 304,131,000 168,837,000 180,691,000 63,548,000 30,944,000 19,535,000 26,497,000 31,979,000 36,861,000 42,546,000 35,553,000 42,565,000 48,778,000 56,706,000 64,982,000 71,784,000 78,859,000 32,113,000 38,172,000 28,725,000 34,134,000 38,867,000 43,151,000 30,835,000 33,344,000 36,331,000 39,021,665 26,382,000 30,381,000 33,865,000 5,564,852 8,309,000 5,535,000 9,390,000 8,201,195      
      accrued clinical trial site costs
    		 1,863,000 1,824,000 1,826,000 1,762,000 1,863,000 2,395,000 3,393,000 3,237,000 3,466,000 3,531,000 3,222,000 2,826,000 3,156,000 3,521,000 3,420,000 3,593,000 3,927,000 4,140,000 3,789,000 3,399,000 3,444,000 2,846,000 1,999,000                      
      accrued interest payable
    		 409,000 423,000                                           
      accumulated other comprehensive gain
    		  226,000 361,000 895,000                                         
      common stock purchase liability
    		     637,000   19,938,000                                     
      accumulated other comprehensive loss
    		     -153,000 -106,000  -1,000    -2,000 -1,000 -2,000                               
      short-term investments
    		      106,780,000                                       
      long-term investments
    		      8,821,000                                       
      2018 pipe warrant liability
    		        653,000  1,000 1,000  2,000 4,000 31,000 170,000 282,000 338,000 539,000 867,000 725,000 1,107,000 1,354,000 590,000 1,145,000 784,000 600,000                  
      operating lease liabilities - current
    		        256,000 212,000                                    
      operating lease liabilities - noncurrent
    		        214,000 273,000                                    
      finance lease right-of-use assets
    		                  13,000 15,000 17,000 20,000 22,000 24,000                      
      operating lease liabilities, net of current
    		                274,000 372,000                            
      2017 pipe warrant liability
    		                    4,777,000 4,230,000 7,656,000 10,822,000 3,667,000 10,202,000 6,274,000 4,563,000 6,641,000 8,036,000 4,927,000 5,076,000              
      due from related party
    		                        9,000 18,000 72,000 64,000                  
      minority interest investment in former subsidiary
    		                         623,000 788,000 978,000                  
      series a warrant liability
    		                        25,000 51,000 73,000 49,000 58,000 1,015,000 291,000 351,713 289,000 415,000 291,000 194,048 509,000 631,000 558,000 1,212,803 1,819,000 2,159,000 3,582,000   
      preferred stock, .001 par value, 10,000,000 shares authorized:
    		                                             
      series b convertible preferred stock, 13,780 shares designated at december 31, 2019 and december 31, 2018; zero shares issued and outstanding at december 31, 2019 and at december 31, 2018. liquidation value of zero.
    		                                             
      accrued compensation and other current liabilities
    		                        1,719,000 1,115,000 992,000 943,000 1,153,000 862,000 721,000 973,054 976,000 879,000 1,237,000 1,169,487 915,000 944,000 1,317,000 1,632,679 1,224,000 1,223,000 438,000 201,457  
      series b convertible preferred stock, 13,780 shares designated at september 30, 2019 and december 31, 2018; zero shares issued and outstanding at september 30, 2019 and at december 31, 2018. liquidation value of zero.
    		                                             
      series b convertible preferred stock, 13,780 shares designated at june 30, 2019 and december 31, 2018; zero shares issued and outstanding at june 30, 2019 and at december 31, 2018. liquidation value of zero.
    		                                             
      series b convertible preferred stock, 13,780 shares designated at march 31, 2019 and december 31, 2018; zero shares issued and outstanding at march 31, 2019 and at december 31, 2018. liquidation value of zero.
    		                                             
      restricted cash
    		                              35,000 35,000 35,000 35,000 35,000 35,000 35,000 35,000 35,000 35,000 111,000 35,000 20,000 20,000 20,000 
      current assets held for sale
    		                            847,000 470,000 484,000 516,373 563,000 2,323,000            
      other assets
    		                             126,000 126,000 125,530 126,000 126,000 126,000 125,530 126,000 76,000 76,000 76,340      
      long-term assets held for sale
    		                            453,000 453,000 453,000 466,387 458,000             
      current liabilities held for sale
    		                            110,000 102,000 88,000 126,611 113,000 214,000            
      series c warrant liability
    		                            2,000 5,000 4,000 5,880 20,000 24,000 57,000 85,490 115,000 193,000 219,000 462,437 581,000 894,000 2,549,000   
      other liabilities
    		                             13,000 13,000 13,163    142,739    109,404 151,000     
      long-term liabilities held for sale
    		                            1,750,000 1,050,000 625,000 225,392              
      series b convertible preferred stock, 13,780 shares designated at december 31, 2018 and december 31, 2017; zero and 4,571 shares issued and outstanding at december 31, 2018 and at december 31, 2017, respectively. liquidation value of zero.
    		                                             
      preferred stock, 0.001 par value, 10,000,000 shares authorized:
    		                                             
      series b convertible preferred stock, 13,780 are designated at september 30, 2018 and december 31, 2017; nil and 4,571 shares issued and outstanding at september 30, 2018 and december 31, 2017, respectively. liquidation value of zero.
    		                                             
      series b convertible preferred stock, 13,780 are designated at june 30, 2018 and december 31, 2017; nil and 4,571 shares issued and outstanding at june 30, 2018 and december 31, 2017, respectively. liquidation value of zero.
    		                                             
      series b convertible preferred stock, 13,780 are designated at march 31, 2018 and december 31, 2017; 3,571 and 4,571 shares issued and outstanding at march 31, 2018 and december 31, 2017, respectively. liquidation value of zero.
    		                                             
      series b convertible preferred stock, 13,780 shares designated at december 31, 2017, and december 31, 2016; 4,571 and 12,780 shares issued and outstanding at december 31, 2017, and at december 31, 2016, respectively. liquidation value of zero.
    		                               5              
      other intangible assets
    		                                19,353,000 19,884,000 21,128,000 817,465 842,000 867,000 892,000 916,807 946,000     
      series b convertible preferred stock, 13,780 are designated at september 30, 2017 and december 31, 2016; 10,049 and 12,780 shares issued and outstanding at september 30, 2017 and at december 31, 2016, respectively. liquidation value of zero.
    		                                             
      series b convertible preferred stock, 13,780 are designated at june 30, 2017 and december 31, 2016; 12,179 and 12,780 shares issued and outstanding at june 30, 2017 and at december 31, 2016, respectively. liquidation value of zero.
    		                                             
      goodwill
    		                                  718,000 718,003 718,000 718,000 718,000 718,003 718,000     
      series b convertible preferred stock, 13,780 are designated at march 31, 2017 and december 31, 2016; 12,179 and 12,780 shares issued and outstanding at march 31, 2017 and at december 31, 2016, respectively. liquidation value of zero.
    		                                             
      series b warrant liability
    		                                       865,000 3,851,000 11,025,000 14,180,000 17,438,731  
      series a convertible preferred stock, 10,000 shares designated; zero and 4,555 issued and outstanding at december 31, 2016 and december 31, 2015, respectively. liquidation value of zero.
    		                                             
      series b convertible preferred stock, 13,780 and zero shares designated at december 31, 2016 and december 31, 2015, respectively; 12,780 and zero shares issued and outstanding at december 31, 2016 and at december 31, 2015, respectively. liquidation value of zero.
    		                                   13          
      series a convertible preferred stock, 10,000 shares designated; zero and 4,555 issued and outstanding at september 30, 2016 and december 31, 2015, respectively
    		                                             
      series b convertible preferred stock, 13,780 and zero shares designated at september 30, 2016 and december 31, 2015, respectively; 13,780 and zero shares issued and outstanding at september 30, 2016 and at december 31, 2015, respectively
    		                                             
      series a convertible preferred stock, 0.001 par value, 40,000 shares authorized, 7,780 and 4,555 issued and outstanding at june 30, 2016 and december 31, 2015, respectively.
    		                                             
      series a convertible preferred stock, 0.001 par value, 40,000 shares authorized, 8,335 and 4,555 issued and outstanding at march 31, 2016 and december 31, 2015, respectively.
    		                                             
      line of credit and accrued interest
    		                                           101,529  
      series a convertible preferred stock, 0.001 par value, 40,000 shares authorized, 4,555 and 0 shares issued and outstanding at december 31, 2015 and december 31, 2014, respectively.
    		                                       5      
      liabilities and stockholders’ deficit
    		                                             
      total long-term liabilities
    		                                        2,551,000 3,053,000 20,311,000   
      stockholders’ deficit
    		                                             
      total stockholders’ deficit
    		                                        -1,291,000 -7,632,000 -11,303,000 -10,332,591 -42,378,000 
      total liabilities and stockholders’ deficit
    		                                        7,288,000 8,770,000 10,067,000 8,395,925 1,696,000 
      government grant revenue
    		                                        155,000 65,000    
      product revenue
    		                                        92,000 32,000    
      total revenue
    		                                        247,000 97,000    
      cost of product revenue
    		                                        56,000 22,000    
      gross profit
    		                                        191,000 75,000 4,000   
      expenses
    		                                             
      research and development
    		                                        1,193,000 1,181,000 878,000 2,242,216 717,000 
      sales and marketing
    		                                        467,000 506,000 260,000 252,359 84,000 
      general and administrative
    		                                        1,714,000 1,432,000 1,292,000 2,665,154 522,000 
      total expenses
    		                                        3,374,000 3,119,000 2,430,000 5,159,729 1,323,000 
      operating income
    		                                        -3,183,000 -3,044,000 -2,426,000 -5,159,729 -1,323,000 
      interest and other income
    		                                             
      interest expense
    		                                           -4,130,394  
      change in fair value of warrants liabilities
    		                                        73,000 4,925,000 -6,174,000   
      other income
    		                                        -183,000 4,925,000  -4,585,475 -318,000 
      inducement charge for series c warrants
    		                                          -3,050,000   
      net income
    		                                        -3,293,000 1,881,000 -11,651,000 -13,874,513  
      basic and diluted net income per common share
    		                                        -330  -1,670 -10.92 -4,470 
      weighted-average common shares outstanding used to calculate basic and diluted net income per common share
    		                                        10,040,079,000  6,965,483,000 1,270,033 535,685,000 
      patent
    		                                         562,000    
      common stock issuable
    		                                         112,000    
      net income per common share:
    		                                             
      basic
    		                                         250    
      diluted
    		                                         250    
      weighted-average common shares outstanding used to calculate net income per common share:
    		                                             
      revenue
    		                                          22,000   
      cost of revenue
    		                                          18,000   
      interest
    		                                          -1,000  -752,000 
      liabilities, convertible preferred stock and stockholders’ deficit
    		                                             
      convertible promissory notes and accrued interest
    		                                             
      convertible preferred stock warrant liability
    		                                            3,066,000 
      commitments
    		                                             
      convertible preferred stock
    		                                             
      series a convertible preferred stock, 0.001 par value, 40,000 shares authorized, 0 and 31,250 shares issued and outstanding at december 31, 2014 and december 31, 2013, respectively;
    		                                             
      series b convertible preferred stock, 0.001 par value, 320,000 shares authorized, 0 and 119,140 shares issued and outstanding at december 31, 2014 and december 31, 2013, respectively;
    		                                             
      series c convertible preferred stock, 0.001 par value, 1,500,000 shares authorized, 0 and 715,039 shares issued and outstanding at december 31, 2014 and december 31, 2013, respectively;
    		                                             
      interest income
    		                                           1,085  
      deferred offering costs
    		                                            1,353,000 
      accrued liabilities
    		                                            358,000 
      convertible promissory notes and accrued interest, net of discounts
    		                                            15,604,000 
      series a convertible preferred stock, 0.001 par value, 40,000 shares authorized, 31,250 shares issued and outstanding at december 31, 2013 and september 30, 2014;
    		                                            1,500,000 
      series b convertible preferred stock, 0.001 par value, 320,000 shares authorized, 119,140 shares issued and outstanding at december 31, 2013 and september 30, 2014;
    		                                            6,863,000 
      series c convertible preferred stock, 0.001 par value, 1,500,000 shares authorized, 715,039 shares issued and outstanding at december 31, 2013 and september 30, 2014;
    		                                            15,445,000 
      net income and comprehensive loss
    		                                            -2,393,000 
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.